Lannett Company Inc. recalls Dextroamphetamine Saccharate
- Recalling company
- Lannett Company Inc.
- Product
- Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
- Reason
- Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 26, 2026
- Reported
- Jul 8, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 1392 bottles
- Lot / codes
- Lot#: 25285401A, Exp. Date: 04/2027
- Company location
- Seymour, IN
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0660-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0660-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.